COST vs. LLY: Costco Wholesale vs. Eli Lilly Stock Comparison
How do Costco Wholesale (COST) and Eli Lilly (LLY) stack up? This page sets them side by side across company profile, performance and risk, profitability, growth, financial strength, dividends, and valuation, with selected fundamentals also measured against each stock's industry-group peers.
Company Profile
Costco Wholesale (COST) is classified in the Consumer Staples sector (Consumer Staples Distribution & Retail), whereas Eli Lilly (LLY) belongs to Health Care (Pharmaceuticals, Biotechnology & Life Sciences) — their GICS classifications point to very different parts of the market.
| Profile Item | COST | LLY |
|---|---|---|
| Name | Costco Wholesale Corp | Eli Lilly and Company |
| Country/Region | United States | United States |
| GICS Sector | Consumer Staples | Health Care |
| GICS Industry Group | Consumer Staples Distribution & Retail | Pharmaceuticals, Biotechnology & Life Sciences |
| GICS Industry | Consumer Staples Distribution & Retail | Pharmaceuticals |
| GICS Sub-Industry | Consumer Staples Merchandise Retail | Pharmaceuticals |
| Market Capitalization | 466.86 billion USD | 1,206.07 billion USD |
| Currency | USD | USD |
| Exchange | Nasdaq | NYSE |
| Listing Date | July 9, 1986 | June 1, 1972 |
| Security Type | Common Stock | Common Stock |
Price Performance
Cumulative Growth
Trailing Returns
Calendar-Year Returns
Performance Metrics
| Metric | COST | LLY |
|---|---|---|
| Total Return (1Y) | 14.87% | 52.36% |
| Total Return (3Y, Annualized) | 24.84% | 34.18% |
| Total Return (5Y, Annualized) | 16.92% | 41.08% |
Risk Profile
Drawdown History
Return Distribution
Risk Metrics
| Metric | COST | LLY |
|---|---|---|
| Volatility (1Y, Annualized) | 20.30% | 35.34% |
| Beta (5Y) | 0.84 | 0.40 |
| Max Drawdown (5Y) | -31.40% | -34.48% |
| Avg. Volume (3M) | 2.15M | 2.52M |
Risk-Adjusted Performance
Risk-Return Positioning
Risk-Adjusted Metrics
| Metric | COST | LLY |
|---|---|---|
| Sharpe Ratio (1Y) | 0.52 | 1.36 |
| Sortino Ratio (1Y) | 0.77 | 2.29 |
Profitability
ROE (TTM)
Both Costco Wholesale (COST) at 28.40% and Eli Lilly (LLY) at 86.02% sit in the top peer quartile for ROE, suggesting each generates more profit from shareholders’ equity than typical industry peers.
COST
Consumer Staples Distribution & Retail industry group
28.40%
- Max
- 33.48%
- COST
- 28.40%
- Q3
- 22.31%
- Median
- 15.57%
- Q1
- 7.66%
- Min
- -2.27%
LLY
Pharmaceuticals, Biotechnology & Life Sciences industry group
86.02%
- Max
- 109.18%
- LLY
- 86.02%
- Q3
- 6.23%
- Median
- -26.66%
- Q1
- -64.05%
- Min
- -167.77%
Net Margin (TTM)
Eli Lilly (LLY) at 31.90% converts revenue to bottom-line profit above its industry’s benchmark range, while Costco Wholesale (COST) at 3.04% keeps roughly the typical share for its industry.
COST
Consumer Staples Distribution & Retail industry group
3.04%
- Max
- 5.45%
- Q3
- 3.42%
- COST
- 3.04%
- Median
- 2.44%
- Q1
- 1.86%
- Min
- -0.06%
LLY
Pharmaceuticals, Biotechnology & Life Sciences industry group
31.90%
- LLY
- 31.90%
- Max
- 18.05%
- Q3
- 4.78%
- Median
- 0.00%
- Q1
- -4.14%
- Min
- -17.05%
Operating Margin (TTM)
Eli Lilly (LLY) at 53.66% operates in the top operating margin quartile, ahead of Costco Wholesale (COST) at 3.79%, which runs around its industry’s norm.
COST
Consumer Staples Distribution & Retail industry group
3.79%
- Max
- 6.81%
- Q3
- 5.49%
- Median
- 3.84%
- COST
- 3.79%
- Q1
- 2.00%
- Min
- 0.97%
LLY
Pharmaceuticals, Biotechnology & Life Sciences industry group
53.66%
- Max
- 83.12%
- LLY
- 53.66%
- Q3
- 14.77%
- Median
- 0.00%
- Q1
- -78.82%
- Min
- -207.40%
Profitability Metrics
| Metric | COST | LLY |
|---|---|---|
| ROE (TTM) | 28.40% | 86.02% |
| ROA (TTM) | 8.66% | 21.06% |
| Net Margin (TTM) | 3.04% | 31.90% |
| Operating Margin (TTM) | 3.79% | 53.66% |
| Gross Margin (TTM) | 12.77% | 83.63% |
Growth
Revenue Growth
Both Costco Wholesale (COST) at 10.14% and Eli Lilly (LLY) at 44.70% land near their industries' usual revenue growth ranges, so top-line momentum looks broadly in line with peers on both sides.
EPS Growth
Only one side can be read here: Eli Lilly (LLY) reports EPS growth of 95.99%, ranked against its industry; Costco Wholesale (COST) has no EPS growth figure this period.
Growth Metrics
| Metric | COST | LLY |
|---|---|---|
| Revenue Growth (YoY) | 10.14% | 44.70% |
| Revenue Growth (3Y CAGR) | 7.76% | 31.69% |
| EPS Growth (YoY) | -- | 95.99% |
| EPS Growth (3Y CAGR) | -- | 51.71% |
Financial Strength
Current Ratio (MRQ)
Costco Wholesale (COST) at 1.06 keeps current ratio within its industry’s typical mid-range, while Eli Lilly (LLY) at 1.39 runs in the tighter-liquidity quartile — a thinner cushion against current liabilities for LLY.
COST
Consumer Staples Distribution & Retail industry group
1.06
- Max
- 2.04
- Q3
- 1.45
- Median
- 1.17
- COST
- 1.06
- Q1
- 1.00
- Min
- 0.69
LLY
Pharmaceuticals, Biotechnology & Life Sciences industry group
1.39
- Max
- 25.13
- Q3
- 12.13
- Median
- 5.52
- Q1
- 2.47
- LLY
- 1.39
- Min
- 0.10
Debt / Equity (MRQ)
Costco Wholesale (COST) at 0.28 keeps leverage in the lower quartile, while Eli Lilly (LLY) at 1.23 sits in the higher-leverage quartile.
COST
Consumer Staples Distribution & Retail industry group
0.28
- Max
- 2.59
- Q3
- 1.83
- Median
- 1.24
- Q1
- 0.63
- COST
- 0.28
- Min
- 0.01
LLY
Pharmaceuticals, Biotechnology & Life Sciences industry group
1.23
- Max
- 1.42
- LLY
- 1.23
- Q3
- 0.65
- Median
- 0.15
- Q1
- 0.02
- Min
- 0.00
Financial Strength Metrics
| Metric | COST | LLY |
|---|---|---|
| Current Ratio (MRQ) | 1.06 | 1.39 |
| Debt / Equity (MRQ) | 0.28 | 1.23 |
| Net Debt / EBITDA | -0.78 | 0.96 |
Dividends
Dividend Yield (TTM)
Costco Wholesale (COST) at 0.52% pays an industry-typical yield; Eli Lilly (LLY) at 0.49% is above its entire peer range — the higher number, but one that calls for a look at payout sustainability before treating it as an advantage.
COST
Consumer Staples Distribution & Retail industry group
0.52%
- Max
- 2.90%
- Q3
- 1.72%
- COST
- 0.52%
- Median
- 0.43%
- Q1
- 0.00%
- Min
- 0.00%
LLY
Pharmaceuticals, Biotechnology & Life Sciences industry group
0.49%
- LLY
- 0.49%
- Max
- 0.00%
- Q3
- 0.00%
- Median
- 0.00%
- Q1
- 0.00%
- Min
- 0.00%
Dividend Payout Ratio (TTM)
Costco Wholesale (COST) at 26.69% keeps its payout in the industry’s typical band, while Eli Lilly (LLY) at 21.71% pays out more than any of its peers — the most stretched cover in its group.
COST
Consumer Staples Distribution & Retail industry group
26.69%
- Max
- 57.98%
- Q3
- 30.05%
- COST
- 26.69%
- Median
- 11.72%
- Q1
- 0.00%
- Min
- 0.00%
LLY
Pharmaceuticals, Biotechnology & Life Sciences industry group
21.71%
- LLY
- 21.71%
- Max
- 0.00%
- Q3
- 0.00%
- Median
- 0.00%
- Q1
- 0.00%
- Min
- 0.00%
Dividend Metrics
| Metric | COST | LLY |
|---|---|---|
| Dividend Yield (TTM) | 0.52% | 0.49% |
| Dividend Payout Ratio (TTM) | 26.69% | 21.71% |
Valuation
P/E Ratio (TTM)
Both Costco Wholesale (COST) at 50.75 and Eli Lilly (LLY) at 43.95 sit in the richer earnings-multiple quartile for P/E ratio, so investors are paying more for TTM earnings than they pay for typical peers.
COST
Consumer Staples Distribution & Retail industry group
50.75
- COST
- 50.75
- Max
- 50.75
- Q3
- 33.64
- Median
- 22.19
- Q1
- 16.09
- Min
- 9.28
LLY
Pharmaceuticals, Biotechnology & Life Sciences industry group
43.95
- Max
- 85.34
- LLY
- 43.95
- Q3
- 43.46
- Median
- 26.69
- Q1
- 13.30
- Min
- 0.07
P/S Ratio (TTM)
Eli Lilly (LLY) at 13.95 is priced about in line with its industry on P/S ratio, while Costco Wholesale (COST) at 1.54 sits in the pricier quartile — COST costs more per dollar of sales.
COST
Consumer Staples Distribution & Retail industry group
1.54
- COST
- 1.54
- Max
- 1.54
- Q3
- 0.81
- Median
- 0.47
- Q1
- 0.26
- Min
- 0.02
LLY
Pharmaceuticals, Biotechnology & Life Sciences industry group
13.95
- Max
- 58.18
- Q3
- 25.77
- LLY
- 13.95
- Median
- 7.30
- Q1
- 3.01
- Min
- 0.01
P/B Ratio (MRQ)
Measured against book value, both Costco Wholesale (COST) at 13.04 and Eli Lilly (LLY) at 29.96 look expensive — each P/B ratio sits above its industry’s benchmark range.
COST
Consumer Staples Distribution & Retail industry group
13.04
- COST
- 13.04
- Max
- 10.15
- Q3
- 6.27
- Median
- 3.70
- Q1
- 1.85
- Min
- 0.93
LLY
Pharmaceuticals, Biotechnology & Life Sciences industry group
29.96
- LLY
- 29.96
- Max
- 13.53
- Q3
- 6.54
- Median
- 3.25
- Q1
- 1.69
- Min
- -5.59
Valuation Metrics
| Metric | COST | LLY |
|---|---|---|
| P/E Ratio (TTM) | 50.75 | 43.95 |
| P/S Ratio (TTM) | 1.54 | 13.95 |
| P/B Ratio (MRQ) | 13.04 | 29.96 |
| Free Cash Flow Yield (TTM) | 1.45% | 0.77% |